ID
32450
Beschreibung
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Stichworte
Versionen (2)
- 16.05.17 16.05.17 -
- 01.11.18 01.11.18 - Sarah Riepenhausen
Rechteinhaber
German Hodgkin Study Group
Hochgeladen am
1. November 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
German Hodgkin Study Group Study HD16/HD17/HD18 Anamnesis Report G6AN DRKS00003455 DRKS00003457
Deutsche Hodgkin Studiengruppe: G6AN Anamnesebogen
- StudyEvent: ODM
Beschreibung
Beschwerden des Patienten
Alias
- UMLS CUI-1
- C3469071
Beschreibung
B-Symptoms
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1706867
Beschreibung
Weight loss
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0936227
Beschreibung
Fever
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0015967
Beschreibung
Night sweats
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0028081
Beschreibung
Other symptoms
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0029625
Beschreibung
Pruritus
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0033774
Beschreibung
Alcohol-induced pain
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1277603
Beschreibung
Laborwerte
Alias
- UMLS CUI-1
- C0022877
Beschreibung
ESR
Datentyp
integer
Maßeinheiten
- mm/1. h
Alias
- UMLS CUI [1]
- C1176468
Beschreibung
WBC
Datentyp
float
Maßeinheiten
- x10^3/µl
Alias
- UMLS CUI [1]
- C0023508
Beschreibung
Lymphocytes
Datentyp
integer
Maßeinheiten
- %
Alias
- UMLS CUI [1]
- C0200635
Beschreibung
Platelets
Datentyp
integer
Maßeinheiten
- x10^3/µl
Alias
- UMLS CUI [1]
- C0005821
Beschreibung
Erythrocytes
Datentyp
float
Maßeinheiten
- x10^6/µl
Alias
- UMLS CUI [1]
- C0362910
Beschreibung
Hb
Datentyp
float
Maßeinheiten
- g/dl
Alias
- UMLS CUI [1]
- C0518015
Beschreibung
Hb
Datentyp
float
Maßeinheiten
- mmol/l
Alias
- UMLS CUI [1]
- C0518015
Beschreibung
Albumin
Datentyp
float
Maßeinheiten
- g/dl
Alias
- UMLS CUI [1]
- C0201838
Beschreibung
falls Albumin absolut nicht erhoben
Datentyp
float
Maßeinheiten
- g/dl
Alias
- UMLS CUI [1]
- C0555903
Beschreibung
Falls Albumin absolut nicht erhoben
Datentyp
integer
Maßeinheiten
- %
Alias
- UMLS CUI [1]
- C0201838
Beschreibung
Creatinine clearance
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0373595
Beschreibung
Aktivitätsindex (nach WHO)
Alias
- UMLS CUI-1
- C1298651
Beschreibung
WHO Performance status
Datentyp
integer
Alias
- UMLS CUI [1]
- C1298650
Beschreibung
Body weight
Datentyp
integer
Maßeinheiten
- kg
Alias
- UMLS CUI [1]
- C0005910
Beschreibung
Body Height
Datentyp
integer
Maßeinheiten
- cm
Alias
- UMLS CUI [1]
- C0005890
Beschreibung
Body surface
Datentyp
float
Maßeinheiten
- m2
Alias
- UMLS CUI [1]
- C0005902
Beschreibung
Begleiterkrankungen
Alias
- UMLS CUI-1
- C0150941
Beschreibung
Concomitant diseases that are not in exclusion criteria
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0150941
- UMLS CUI [1,2]
- C0332300
- UMLS CUI [1,3]
- C0680251
Beschreibung
Concomitant diseases
Datentyp
text
Alias
- UMLS CUI [1]
- C0150941
Beschreibung
Infectious mononucleosis
Datentyp
integer
Alias
- UMLS CUI [1]
- C0021345
Beschreibung
Familienanamnese
Alias
- UMLS CUI-1
- C0241889
Beschreibung
Malignant or benign hematological diseases within the family
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0018939
- UMLS CUI [1,2]
- C0205282
- UMLS CUI [2,1]
- C0018939
- UMLS CUI [2,2]
- C0205183
Beschreibung
Hodgkin Lymphoma
Datentyp
integer
Alias
- UMLS CUI [1]
- C0019829
Beschreibung
Non Hodgkin Lymphoma
Datentyp
integer
Alias
- UMLS CUI [1]
- C0024305
Beschreibung
CML
Datentyp
integer
Alias
- UMLS CUI [1]
- C0023473
Beschreibung
CLL
Datentyp
integer
Alias
- UMLS CUI [1]
- C0023434
Beschreibung
AML
Datentyp
integer
Alias
- UMLS CUI [1]
- C0023467
Beschreibung
ALL
Datentyp
integer
Alias
- UMLS CUI [1]
- C0023449
Beschreibung
Multiple Myeloma
Datentyp
integer
Alias
- UMLS CUI [1]
- C0026764
Beschreibung
Multiple Sclerosis
Datentyp
integer
Alias
- UMLS CUI [1]
- C0026769
Beschreibung
Sarcoidosis
Datentyp
integer
Alias
- UMLS CUI [1]
- C0036202
Beschreibung
Bemerkungen
Alias
- UMLS CUI-1
- C0947611
Ähnliche Modelle
Deutsche Hodgkin Studiengruppe: G6AN Anamnesebogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C1442065 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0332300 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,3])
(Comment:de)
(Comment:de)
(Comment:de)
C0205282 (UMLS CUI [1,2])
C0018939 (UMLS CUI [2,1])
C0205183 (UMLS CUI [2,2])
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)
(Comment:de)